Signal Transduction and Targeted Therapy

Journal Title
Signal Transduction and Targeted Therapy

SIGNAL TRANSDUCT TAR

ISSN / eISSN
2095-9907 / 2059-3635
Aims and Scope
Signal Transduction and Targeted Therapy (ISSN 2059-3635 (online), ISSN 2095-9907 (print), CN 51-1758/R) is a new open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, including but not limited to: cancer, cardiovascular diseases, autoimmune diseases, and nervous system diseases.
Subject Area

BIOCHEMISTRY & MOLECULAR BIOLOGY

CELL BIOLOGY

CiteScore
44.50 View Trend
CiteScore Ranking
Category Quartile Rank
Biochemistry, Genetics and Molecular Biology - Genetics Q1 #2/347
Biochemistry, Genetics and Molecular Biology - Cancer Research Q1 #5/230
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2024) Quartile
BIOCHEMISTRY & MOLECULAR BIOLOGY Q1
CELL BIOLOGY Q1
Country/Area of Publication
United Kingdom
Publisher
Springer Nature
Year Publication Started
2016
Annual Article Volume
272
Open Access
YES
Contact
CAMPUS, 4 CRINAN ST, LONDON, ENGLAND, N1 9XW
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
Although the impact factor is increasing rapidly, most of the impact factors are achieved through letter publications, and it is easier to be accepted by submitting in letter format. However, it is important to remind everyone that a small number of institutions have regulations that letters (excluding Nature's letters) are not considered articles and cannot be used for promotion or awards. Considering this trend, the publication volume of letters in domestic journals is very high, leading to internal competition, and only raising assessment standards. I believe that this trend will continue to spread in the future. Those who want to go far in scientific research should carefully consider submitting letters, including letters from Cell Research, as they may no longer be considered articles in the future.
2021-03-26
I don't understand why there are so many sour grape mentality people who can't stand to see domestic journals improve. Is mindlessly criticizing interesting? If you have the ability, publish an article there and then speak. Anyway, if our papers are not accepted by top-tier journals or major journals, we will consider submitting them here, but it is also difficult to get accepted. Many papers that were rejected by STTT were accepted by NC, and there are quite a few accepted by Cell Reports. At the very least, this proves that STTT has a higher difficulty level for manuscript submission compared to regular journals.
2023-08-09

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now